Selective Serotonin Reuptake Inhibitors and Cosmetic Psychopharmacology: Ethical and Deontological Dilemmas

Virkkunen M. , Rawlings R. , Tokola R. “CFS Biochemistries. Glucose Metabolism, and Diurnal Activity Rhythms in Alcoholic, Violent Offenders. Fire Setters, and Healthy Volunteers,” Arch Gen Psychiatry. (1994) 51: 20–27; F.G. Moeller, D.M. Dougherty, A.C. Swann, “Tryptophan Depletion and Aggressive Response in Healthy Males.” Psychopharmacology, (Berl.) (1996) 126: 97-103.

Fuller R.W. “The Influence of Fluoxetine on Aggressive Behavior, Neuropsychopharmacolog, 1996) 14: 77–81.

Graham B. “Meditating on Prozac.” Common Boundary, (1994) Settembre/ Ottobre: 24–30.

Rotman D.J. “Shiny, Happy People.” The New Republic, (1994) 14: 34–38.

Sperry L. , Prosen H. “Contemporary Ethical Dilemmas in Psychotherapy: Cosmetic Psychopharmacology and Managed Care.” Am J Psychotherapy, (1998) 52(1): 54–63.

Kramer P. Listening to Prozac: A Psychiatrist Explores Antidepressant Drugs and Remaking of the Self. (Viking, New York, 1993).

Knutsonl B. , Wolkowitz O.M. , Cole S.W. “Selective Alteration of Personality and Social Behavior by Serotonininergic Intervention,” Am J Psychotherapy (1998) 155: 373–379.

Sperry. Prosen, op cit.